ListedMainboardPharmaceuticals & DrugsSENORES
Senores Pharmaceuticals IPO
Senores Pharmaceuticals IPO is a mainboard IPO raising ₹582 Cr at ₹372 – ₹391 a share. It listed on 30 Dec 2024 and trades at ₹1,328 today, +239.6% against its issue price of ₹391. It was subscribed 94× in total.
₹391
Issue price
₹1,328
Price now
+239.6%
Since issue price
30 Dec 2024
Listed on
94×Subscribed (final) · all exchanges
93.7 times more demand than shares on offer
populated partly populated we hold nothing here — the tab says why
Lead managers, and how their past issues have done
Median return since issue price across every IPO we hold this bank on. Not a forecast for this issue — a record.
| Lead manager | IPOs we hold them on | Of which we can price | Median return since issue |
|---|---|---|---|
| Equirus Capital Private Limited | 32 | 28 | +15.0% |
| Ambit Private Limited | 12 | 9 | +101.3% |
| Nuvama Wealth Management Limited | 27 | 26 | −15.9% |
A bank appears on an issue we can price only when the company is matched to our price history, so the two counts differ. See the full league table →
Registrar
Contact them about allotment, refunds or unblocking your application amount — not the company, and not the exchange.
NameLink Intime India Private Limited
ContactShantiGopalkrishnan
Emailsenorespharma.ipo@linkintime.co.in
Phone+91 8108114949